PLx Pharma Inc. to Present at JMP Securities 2022 Life Sciences Conference on June 15, 2022
|Webcast (live and replay)||https://wsw.com/webcast/jmp54/plxp/1705536
The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via PLx Pharma’s investor relations website at https://ir.plxpharma.com/events-presentations/events.
VAZALORE is an FDA-approved liquid-filled aspirin capsule, available in 81 mg and 325 mg doses. VAZALORE delivers aspirin differently from plain and enteric coated aspirin products. The special complex inside the capsule is designed for targeted release of aspirin, limiting its direct contact with the stomach. VAZALORE delivers fast, reliable absorption for pain relief plus the lifesaving benefits of aspirin. To learn more about VAZALORE, please visit www.vazalore.com.
Vice President, Investor Relations
Founder & President, In-Site Communications, Inc.
Source: PLx Pharma Inc.